Wellness Testing
We are setting the standard
At Variantyx, we are setting the standard of genome analysis. We are leading the way by offering the most comprehensive predictive testing available for disease predisposition and carrier status. With thorough interrogation of the genome, we have the ability to detect all major clinically relevant variant types from one sample. A single, unified clinical report is generated with thorough variant evaluation performed by clinical experts.
Using our methodology’s superior analytical and clinical validity, we are providing better overall performance and the most complete assessment of disease risk and carrier status. All with a single test, and a single cost.
Our methodology preserves genomic data
A wide variety of DNA changes lead to disease predisposition. Comprehensive detection of all major clinically relevant variant types requires the right technology. PCR-free whole genome sequencing (WGS) generates uniform coverage of >98% of the patient’s DNA. Compare that to PCR-based panel and exome technologies that remove and skew data, generating fragmented coverage of only 1-2% of the patient’s DNA.
Pairing WGS with our Genomic Intelligence® proprietary analytical software provides the most complete picture possible of the changes in an individual’s genome.
Our wellness test
Genomic Inform® This test provides information about risks across multiple health areas including: cancer conditions, neurological disorders, metabolic disorders, heart conditions, bleeding disorders, carrier findings in >600 genes associated with severe early-onset disease, pharmacogenomic status (optional).